Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis

AIMS/HYPOTHESIS: Epidemiological studies have generated conflicting findings on the relationship between glucose-lowering medication use and cancer risk. Naturally occurring variation in genes encoding glucose-lowering drug targets can be used to investigate the effect of their pharmacological pertu...

Descripción completa

Detalles Bibliográficos
Autores principales: Yarmolinsky, James, Bouras, Emmanouil, Constantinescu, Andrei, Burrows, Kimberley, Bull, Caroline J., Vincent, Emma E., Martin, Richard M., Dimopoulou, Olympia, Lewis, Sarah J., Moreno, Victor, Vujkovic, Marijana, Chang, Kyong-Mi, Voight, Benjamin F., Tsao, Philip S., Gunter, Marc J., Hampe, Jochen, Pellatt, Andrew J., Pharoah, Paul D. P., Schoen, Robert E., Gallinger, Steven, Jenkins, Mark A., Pai, Rish K., Gill, Dipender, Tsilidis, Kostas K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317892/
https://www.ncbi.nlm.nih.gov/pubmed/37171501
http://dx.doi.org/10.1007/s00125-023-05925-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317892/
https://www.ncbi.nlm.nih.gov/pubmed/37171501
http://dx.doi.org/10.1007/s00125-023-05925-4

Ejemplares similares